COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies

Type 2 diabetes mellitus, obesity, hypertension, and other associated metabolic complications have been demonstrated as a crucial contributor to the enhanced morbidity and mortality of patients with coronavirus disease 2019 (COVID-19). Data on the interplay between metabolic comorbidities and the ou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Pharmacother
Main Authors: Hua, Shuang, Yang, Yong, Zou, Danqi, Li, Jufei, Yan, Kaixuan, Xu, Ying, Jiang, Xue, Rong, Xianglu, Ye, Dewei
Formato: Artigo
Idioma:Inglês
Publicado em: The Author(s). Published by Elsevier Masson SAS. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8101987/
https://ncbi.nlm.nih.gov/pubmed/34015585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2021.111685
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados